Iradimed (IRMD) Scheduled to Post Earnings on Thursday

Iradimed (NASDAQ:IRMD - Get Free Report) is set to issue its quarterly earnings data before the market opens on Thursday, October 31st. Analysts expect the company to announce earnings of $0.35 per share for the quarter. Iradimed has set its FY 2024 guidance at 1.520-1.620 EPS and its Q3 2024 guidance at 0.380-0.410 EPS.

Iradimed (NASDAQ:IRMD - Get Free Report) last released its earnings results on Thursday, August 1st. The medical equipment provider reported $0.38 EPS for the quarter, beating analysts' consensus estimates of $0.33 by $0.05. The company had revenue of $17.93 million during the quarter, compared to analysts' expectations of $17.70 million. Iradimed had a return on equity of 24.71% and a net margin of 26.83%. During the same quarter last year, the business posted $0.33 EPS. On average, analysts expect Iradimed to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Iradimed Trading Down 0.2 %

Iradimed stock traded down $0.12 on Friday, hitting $50.39. 20,108 shares of the stock traded hands, compared to its average volume of 49,371. The business's fifty day simple moving average is $48.24 and its 200 day simple moving average is $45.14. The firm has a market cap of $638.14 million, a P/E ratio of 35.82 and a beta of 0.79. Iradimed has a 1 year low of $38.67 and a 1 year high of $52.45.

Iradimed Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 30th. Shareholders of record on Tuesday, August 20th were issued a $0.15 dividend. This represents a $0.60 dividend on an annualized basis and a yield of 1.19%. The ex-dividend date of this dividend was Tuesday, August 20th. Iradimed's dividend payout ratio (DPR) is presently 42.55%.

Wall Street Analysts Forecast Growth

Separately, Roth Mkm dropped their price target on Iradimed from $65.00 to $60.00 and set a "buy" rating on the stock in a research report on Friday, August 2nd.

About Iradimed

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with RALU ferromagnetic detection device.